Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 447

1.

Surgical Resection of Colorectal Cancer With Distant Metastases to Other than Liver or Lung.

Naito A, Kagawa Y, Kawai K, Takeno A, Takeda Y, Ohtsuka M, Suzuki Y, Imasato M, Fujie Y, Nakaba H, Akamatsu H, Murata K.

In Vivo. 2019 Sep-Oct;33(5):1605-1608. doi: 10.21873/invivo.11643.

2.

Subgroup Analysis of Japanese Patients in a Phase III Study of Atezolizumab in Extensive-stage Small-cell Lung Cancer (IMpower133).

Nishio M, Sugawara S, Atagi S, Akamatsu H, Sakai H, Okamoto I, Takayama K, Hayashi H, Nakagawa Y, Kawakami T.

Clin Lung Cancer. 2019 Jul 31. pii: S1525-7304(19)30209-8. doi: 10.1016/j.cllc.2019.07.005. [Epub ahead of print]

PMID:
31466854
3.

Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer.

Udagawa H, Akamatsu H, Tanaka K, Takeda M, Kanda S, Kirita K, Teraoka S, Nakagawa K, Fujiwara Y, Yasuda I, Okubo S, Shintani M, Kosloski MP, Scripture C, Tamura T, Okamoto I.

Lung Cancer. 2019 Sep;135:145-150. doi: 10.1016/j.lungcan.2019.07.025. Epub 2019 Jul 24.

PMID:
31446987
4.

Association between bovine leukemia virus proviral load and severity of clinical mastitis.

Watanabe A, Murakami H, Kakinuma S, Murao K, Ohmae K, Isobe N, Akamatsu H, Seto T, Hashimura S, Konda K, Shinozuka Y, Kawai K.

J Vet Med Sci. 2019 Oct 18;81(10):1431-1437. doi: 10.1292/jvms.19-0285. Epub 2019 Aug 12.

5.

Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia.

Ogura T, Takigawa N, Tomii K, Kishi K, Inoue Y, Ichihara E, Homma S, Takahashi K, Akamatsu H, Ikeda S, Inase N, Iwasawa T, Ohe Y, Ohta H, Onishi H, Okamoto I, Ogawa K, Kasahara K, Karata H, Kishimoto T, Kitamura Y, Gemma A, Kenmotsu H, Sakashita H, Sakamoto S, Sekine K, Takiguchi Y, Tada Y, Toyooka S, Nakayama Y, Nishioka Y, Hagiwara K, Hanibuchi M, Fukuoka J, Minegishi Y, Yanagihara T, Yamamoto N, Yamamoto H, Gaga M, Fong KM, Powell CA, Kiura K; DLD/TO Assemblies of JRS.

Respir Investig. 2019 Jul 31. pii: S2212-5345(18)30312-5. doi: 10.1016/j.resinv.2019.06.001. [Epub ahead of print] Review.

PMID:
31377122
6.

Variation in the Resistance of Japanese Soybean Cultivars to Phytophthora Root and Stem Rot during the Early Plant Growth Stages and the Effects of a Fungicide Seed Treatment.

Akamatsu H, Kato M, Ochi S, Mimuro G, Matsuoka JI, Takahashi M.

Plant Pathol J. 2019 Jun;35(3):219-233. doi: 10.5423/PPJ.OA.11.2018.0252. Epub 2019 Jun 1.

7.

Laparoscopic splenectomy for isolated splenic sarcoidosis: A case report.

Mikamori M, Tanemura M, Furukawa K, Saito T, Ohtsuka M, Suzuki Y, Imasato M, Kishi K, Akamatsu H.

Int J Surg Case Rep. 2019;60:79-81. doi: 10.1016/j.ijscr.2019.04.031. Epub 2019 Apr 19.

8.

[A Case of Myeloid Sarcoma That Primarily Developed in the Spleen].

Kado T, Tanemura M, Furukawa K, Mikamori M, Saito T, Ohtsuka M, Suzuki Y, Imasato M, Kishi K, Akamatsu H.

Gan To Kagaku Ryoho. 2019 Apr;46(4):784-786. Japanese.

PMID:
31164535
9.

A six-degree-of-freedom micro-vibration acoustic isolator for low-temperature radiation detectors based on superconducting transition-edge sensors.

Gottardi L, van Weers H, Dercksen J, Akamatsu H, Bruijn MP, Gao JR, Jackson B, Khosropanah P, van der Kuur J, Ravensberg K, Ridder ML.

Rev Sci Instrum. 2019 May;90(5):055107. doi: 10.1063/1.5088364.

PMID:
31153243
10.

Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumab.

Oyanagi J, Koh Y, Sato K, Mori K, Teraoka S, Akamatsu H, Kanai K, Hayata A, Tokudome N, Akamatsu K, Nakanishi M, Ueda H, Yamamoto N.

Lung Cancer. 2019 Jun;132:107-113. doi: 10.1016/j.lungcan.2019.03.020. Epub 2019 Mar 22.

PMID:
31097082
11.

Phase I/II Study of Osimertinib With Bevacizumab in EGFR-mutated, T790M-positive Patients With Progressed EGFR-TKIs: West Japan Oncology Group 8715L (WJOG8715L).

Akamatsu H, Teraoka S, Morita S, Katakami N, Tachihara M, Daga H, Yamamoto N, Nakagawa K.

Clin Lung Cancer. 2019 Jul;20(4):e492-e494. doi: 10.1016/j.cllc.2019.03.002. Epub 2019 Mar 19.

12.

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV.

Akamatsu H, Ninomiya K, Kenmotsu H, Morise M, Daga H, Goto Y, Kozuki T, Miura S, Sasaki T, Tamiya A, Teraoka S, Tsubata Y, Yoshioka H, Hattori Y, Imamura CK, Katsuya Y, Matsui R, Minegishi Y, Mizugaki H, Nosaki K, Okuma Y, Sakamoto S, Sone T, Tanaka K, Umemura S, Yamanaka T, Amano S, Hasegawa K, Morita S, Nakajima K, Maemondo M, Seto T, Yamamoto N.

Int J Clin Oncol. 2019 Jul;24(7):731-770. doi: 10.1007/s10147-019-01431-z. Epub 2019 May 2.

13.

Organ-preserving approach via radiotherapy for small cell carcinoma of the bladder: an analysis based on the Japanese Radiation Oncology Study Group (JROSG) survey.

Akamatsu H, Nakamura K, Ebara T, Inaba K, Itasaka S, Jingu K, Kosaka Y, Murai T, Nagata K, Soejima T, Takahashi S, Toyoda T, Toyoshima S, Nemoto K, Akimoto T.

J Radiat Res. 2019 Jul 1;60(4):509-516. doi: 10.1093/jrr/rrz018.

14.

Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study).

Akamatsu H, Koh Y, Okamoto I, Fujimoto D, Bessho A, Azuma K, Morita S, Yamamoto N, Nakagawa K.

Lung Cancer. 2019 May;131:128-133. doi: 10.1016/j.lungcan.2019.03.021. Epub 2019 Mar 22.

15.

Genetic Profiling of Non-Small Cell Lung Cancer at Development of Resistance to First- or Second-Generation EGFR-TKIs by CAPP-Seq Analysis of Circulating Tumor DNA.

Otsubo K, Sakai K, Takeshita M, Harada D, Azuma K, Ota K, Akamatsu H, Goto K, Horiike A, Kurata T, Nakagaki N, Nosaki K, Iwama E, Nakanishi Y, Nishio K, Okamoto I.

Oncologist. 2019 Aug;24(8):1022-1026. doi: 10.1634/theoncologist.2019-0101. Epub 2019 Apr 25.

PMID:
31023862
16.

UV irradiation-induced DNA hypomethylation around WNT1 gene: Implications for solar lentigines.

Yamada T, Hasegawa S, Iwata Y, Arima M, Kobayashi T, Numata S, Nakata S, Sugiura K, Akamatsu H.

Exp Dermatol. 2019 Jun;28(6):723-729. doi: 10.1111/exd.13949.

PMID:
31020703
17.

Comparison of the Diagnostic Performance of Newly Designed 21-Gauge and Standard 22-Gauge Aspiration Needles in Patients with Solid Pancreatic Masses.

Minaga K, Yoshikawa T, Yamashita Y, Akamatsu H, Ikenouchi M, Ishii T, Matsumoto H, Iwagami H, Nakatani Y, Hatamaru K, Takenaka M, Akamatsu T, Uenoyama Y, Watanabe T, Ono K, Chiba Y, Kudo M.

Dig Dis Sci. 2019 Oct;64(10):2982-2991. doi: 10.1007/s10620-019-05624-4. Epub 2019 Apr 22.

PMID:
31011943
18.

Heterogeneous Expression of Programmed Death Receptor-ligand 1 on Circulating Tumor Cells in Patients With Lung Cancer.

Koh Y, Yagi S, Akamatsu H, Kanai K, Hayata A, Tokudome N, Akamatsu K, Higuchi M, Kanbara H, Nakanishi M, Ueda H, Yamamoto N.

Clin Lung Cancer. 2019 Jul;20(4):270-277.e1. doi: 10.1016/j.cllc.2019.03.004. Epub 2019 Mar 25.

19.

Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer and a poor performance status.

Nakashima K, Kimura M, Akamatsu H, Daga H, Imai H, Taira T, Ko R, Hisamatsu Y, Nishino K, Sugimoto T, Miyashita Y, Takahashi T; et al.

Jpn J Clin Oncol. 2019 Jul 1;49(7):671-675. doi: 10.1093/jjco/hyz041.

PMID:
30920616
20.

[A Case of Cecal Cancer in a Patient with Situs Inversus Treated with Single-Port Laparoscopic Surgery].

Suzuki Y, Ohtsuka M, Tei M, Mikamori M, Saito T, Furukawa K, Kishi K, Tanemura M, Akamatsu H.

Gan To Kagaku Ryoho. 2019 Feb;46(2):386-388. Japanese.

PMID:
30914569
21.

Structural dynamics of LaVO3 on the nanosecond time scale.

Brahlek M, Stoica VA, Lapano J, Zhang L, Akamatsu H, Tung IC, Gopalan V, Walko DA, Wen H, Freeland JW, Engel-Herbert R.

Struct Dyn. 2019 Jan 18;6(1):014502. doi: 10.1063/1.5045704. eCollection 2019 Jan.

22.

Carboplatin Plus Nab-paclitaxel in Performance Status 2 Patients With Advanced Non-small-cell Lung Cancer.

Nakashima K, Akamatsu H, Murakami H, Niwa T, Iwamoto Y, Ozawa Y, Yokoyama T, Shoda H, Yamamoto N, Yoshioka H, Masuda K, Naito T, Mori K, Takahashi T.

Anticancer Res. 2019 Mar;39(3):1463-1468. doi: 10.21873/anticanres.13263.

PMID:
30842183
23.

Clinical Outcome of Single-port Surgery in Patients With Pathologic T4 Colon Cancer.

Tei M, Otsuka M, Suzuki Y, Akamatsu H.

Surg Laparosc Endosc Percutan Tech. 2019 Oct;29(5):367-372. doi: 10.1097/SLE.0000000000000652.

PMID:
30839362
24.

[A Comparative Study on Feasibility of SOX Therapy and SP Therapy with Short Hydration for Gastric Cancer in the Outpatient Setting].

Tamaoka K, Kishi K, Saito T, Mikamori M, Ohtsuka M, Furukawa K, Suzuki Y, Tei M, Tanemura M, Akamatsu H.

Gan To Kagaku Ryoho. 2019 Jan;46(1):187-189. Japanese.

PMID:
30765683
25.

[A Case of Resection of a Huge Intrahepatic Cholangiocarcinoma of Extrahepatic Growth Type].

Inui M, Tanemura M, Furukawa K, Mikamori M, Ohtsuka M, Saito T, Suzuki Y, Imasato M, Kishi K, Akamatsu H.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2300-2302. Japanese.

PMID:
30692444
26.

[A Case of Endometrioid Adenocarcinoma in the Sac of a Femoral Hernia].

Sakano Y, Ohtsuka M, Saito T, Mikamori M, Furukawa K, Suzuki Y, Tei M, Kishi K, Tanemura M, Akamatsu H.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2021-2023. Japanese.

PMID:
30692431
27.

[A Case Report of Sigmoid Colon Cancer with a Synchronous Large Liver Metastasis Curatively Resected Following Multidisciplinary Therapy].

Suzuki Y, Mikamori M, Saito T, Furukawa K, Ohtsuka M, Kishi K, Tanemura M, Akamatsu H.

Gan To Kagaku Ryoho. 2018 Dec;45(13):1979-1981. Japanese.

PMID:
30692417
28.

[Nephrotoxicity of a Short Hydration Method for the Cisplatin Regimen in Patients with Gastric Cancer].

Kishi K, Saito T, Mikamori M, Ohtsuka M, Furukawa K, Suzuki Y, Tei M, Tanemura M, Akamatsu H.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2069-2071. Japanese.

PMID:
30692287
29.

The impact of high PD-L1 expression on the surrogate endpoints and clinical outcomes of anti-PD-1/PD-L1 antibodies in non-small cell lung cancer.

Ito K, Miura S, Sakaguchi T, Murotani K, Horita N, Akamatsu H, Uemura K, Morita S, Yamamoto N.

Lung Cancer. 2019 Feb;128:113-119. doi: 10.1016/j.lungcan.2018.12.023. Epub 2018 Dec 26.

PMID:
30642442
30.

A Phase II Study of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer who Responded to Prior PD-1/L1 Inhibitors: West Japan Oncology Group 9616L (WJOG9616L).

Akamatsu H, Teraoka S, Koh Y, Yamanaka T, Yamamoto N, Nakagawa K.

Clin Lung Cancer. 2019 Mar;20(2):139-141. doi: 10.1016/j.cllc.2018.12.001. Epub 2018 Dec 11.

31.

Sodium titanium oxide bronze nanoparticles synthesized via concurrent reduction and Na+-doping into TiO2(B).

Hasegawa G, Tanaka M, Vequizo JJM, Yamakata A, Hojo H, Kobayashi M, Kakihana M, Inada M, Akamatsu H, Hayashi K.

Nanoscale. 2019 Jan 17;11(3):1442-1450. doi: 10.1039/c8nr08372j.

PMID:
30608497
32.

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer.

John T, Akamatsu H, Delmonte A, Su WC, Lee JS, Chang GC, Huang X, Jenkins S, Wu YL.

Lung Cancer. 2018 Dec;126:133-138. doi: 10.1016/j.lungcan.2018.10.027. Epub 2018 Nov 1.

PMID:
30527177
33.

CXCL12 regulates differentiation of human immature melanocyte precursors as well as their migration.

Yamada T, Hasegawa S, Hasebe Y, Kawagishi-Hotta M, Arima M, Iwata Y, Kobayashi T, Numata S, Yamamoto N, Nakata S, Sugiura K, Akamatsu H.

Arch Dermatol Res. 2019 Jan;311(1):55-62. doi: 10.1007/s00403-018-1880-2. Epub 2018 Nov 27.

PMID:
30483878
34.

Corrigendum to "Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab" [Lung Cancer 115 (2018) 71-74].

Sato K, Akamatsu H, Murakami E, Sasaki S, Kanai K, Hayata A, Tokudome N, Akamatsu K, Koh Y, Ueda H, Nakanishi M, Yamamoto N.

Lung Cancer. 2018 Dec;126:230-231. doi: 10.1016/j.lungcan.2018.11.007. Epub 2018 Nov 18. No abstract available.

35.

Hybrid Improper Ferroelectricity in (Sr,Ca)3Sn2O7 and Beyond: Universal Relationship between Ferroelectric Transition Temperature and Tolerance Factor in n = 2 Ruddlesden-Popper Phases.

Yoshida S, Akamatsu H, Tsuji R, Hernandez O, Padmanabhan H, Sen Gupta A, Gibbs AS, Mibu K, Murai S, Rondinelli JM, Gopalan V, Tanaka K, Fujita K.

J Am Chem Soc. 2018 Nov 21;140(46):15690-15700. doi: 10.1021/jacs.8b07998. Epub 2018 Nov 8.

36.

Extracellular proteoglycan decorin maintains human hair follicle stem cells.

Miyachi K, Yamada T, Kawagishi-Hotta M, Hasebe Y, Date Y, Hasegawa S, Arima M, Iwata Y, Kobayashi T, Numata S, Yamamoto N, Nakata S, Sugiura K, Akamatsu H.

J Dermatol. 2018 Dec;45(12):1403-1410. doi: 10.1111/1346-8138.14678. Epub 2018 Oct 15.

PMID:
30320452
37.

Exploration of resistance mechanisms for epidermal growth factor receptor-tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next-generation sequencing.

Iwama E, Sakai K, Azuma K, Harada D, Nosaki K, Hotta K, Nishio M, Kurata T, Fukuhara T, Akamatsu H, Goto K, Shimose T, Kishimoto J, Nakanishi Y, Nishio K, Okamoto I.

Cancer Sci. 2018 Dec;109(12):3921-3933. doi: 10.1111/cas.13820. Epub 2018 Nov 13.

38.

Primary Intrahepatic Squamous Cell Carcinoma with Histological Collision of Adenocarcinoma and Squamous Cell Carcinoma: A Case Report.

Tamaoka K, Tanemura M, Furukawa K, Mikamori M, Saito T, Ohtsuka M, Suzuki Y, Tei M, Kishi K, Yasuoka H, Tsujimoto M, Akamatsu H.

Am J Case Rep. 2018 Oct 5;19:1184-1191. doi: 10.12659/AJCR.910676.

39.

A Phase II Study of Gefitinib With Concurrent Thoracic Radiotherapy in Patients With Unresectable, Stage III Non-small-cell Lung Cancer Harboring EGFR Mutations (WJOG6911L).

Akamatsu H, Harada H, Tokunaga S, Yoshimura N, Ikeda H, Oizumi S, Sugimoto N, Takano T, Murakami H, Nishimura Y, Yamamoto N, Nakagawa K.

Clin Lung Cancer. 2019 Jan;20(1):e25-e27. doi: 10.1016/j.cllc.2018.08.017. Epub 2018 Aug 30.

40.

Osimertinib With Ramucirumab in EGFR-mutated, T790M-positive Patients With Progression During EGFR-TKI Therapy: Phase Ib Study.

Akamatsu H, Koh Y, Ozawa Y, Fujimoto D, Hata A, Katakami N, Tomii K, Shimokawa T, Yamamoto N.

Clin Lung Cancer. 2018 Nov;19(6):e871-e874. doi: 10.1016/j.cllc.2018.08.001. Epub 2018 Aug 22.

41.

MicroRNA-137-mediated Src oncogenic signaling promotes cancer progression.

Kokuda R, Watanabe R, Okuzaki D, Akamatsu H, Oneyama C.

Genes Cells. 2018 Jul 2. doi: 10.1111/gtc.12610. [Epub ahead of print]

42.

Safety and feasibility of single-port laparoscopic multivisceral resection for locally advanced left colon cancer.

Tei M, Otsuka M, Suzuki Y, Kishi K, Tanemura M, Akamatsu H.

Oncol Lett. 2018 Jun;15(6):10091-10097. doi: 10.3892/ol.2018.8582. Epub 2018 Apr 26.

43.

Japanese Dermatological Association Guidelines: Guidelines for the treatment of acne vulgaris 2017.

Hayashi N, Akamatsu H, Iwatsuki K, Shimada-Omori R, Kaminaka C, Kurokawa I, Kono T, Kobayashi M, Tanioka M, Furukawa F, Furumura M, Yamasaki O, Yamasaki K, Yamamoto Y, Miyachi Y, Kawashima M.

J Dermatol. 2018 Aug;45(8):898-935. doi: 10.1111/1346-8138.14355. Epub 2018 May 21.

PMID:
29782039
44.

Safety and Feasibility of Single-port Surgery for Colon Cancer in Octogenarians.

Tei M, Otsuka M, Suzuki Y, Kishi K, Tanemura M, Akamatsu H.

Anticancer Res. 2018 May;38(5):2967-2972.

PMID:
29715125
45.

Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial.

Akamatsu H, Katakami N, Okamoto I, Kato T, Kim YH, Imamura F, Shinkai M, Hodge RA, Uchida H, Hida T.

Cancer Sci. 2018 Jun;109(6):1930-1938. doi: 10.1111/cas.13623. Epub 2018 May 31.

46.

Clinical Outcomes of Single-port Surgery for Colon Cancer in Octogenarians.

Tei M, Otsuka M, Suzuki Y, Kishi K, Tanemura M, Akamatsu H.

Surg Laparosc Endosc Percutan Tech. 2018 Jun;28(3):164-169. doi: 10.1097/SLE.0000000000000524.

PMID:
29672345
47.

Artificial two-dimensional polar metal at room temperature.

Cao Y, Wang Z, Park SY, Yuan Y, Liu X, Nikitin SM, Akamatsu H, Kareev M, Middey S, Meyers D, Thompson P, Ryan PJ, Shafer P, N'Diaye A, Arenholz E, Gopalan V, Zhu Y, Rabe KM, Chakhalian J.

Nat Commun. 2018 Apr 18;9(1):1547. doi: 10.1038/s41467-018-03964-9.

48.

[Chemoradiotherapy Using Molecular Targeted Therapy].

Akamatsu H.

Gan To Kagaku Ryoho. 2018 Mar;45(3):416-418. Japanese.

PMID:
29650895
49.

Safety and feasibility of single-port laparoscopic low anterior resection for upper rectal cancer.

Tei M, Otsuka M, Suzuki Y, Kishi K, Tanemura M, Akamatsu H.

Am J Surg. 2018 Dec;216(6):1101-1106. doi: 10.1016/j.amjsurg.2018.03.022. Epub 2018 Mar 26.

PMID:
29631909
50.

Laminin-332 regulates differentiation of human interfollicular epidermal stem cells.

Yamada T, Hasegawa S, Miyachi K, Date Y, Inoue Y, Yagami A, Arima M, Iwata Y, Yamamoto N, Nakata S, Matsunaga K, Sugiura K, Akamatsu H.

Mech Ageing Dev. 2018 Apr;171:37-46. doi: 10.1016/j.mad.2018.03.007. Epub 2018 Mar 16.

PMID:
29555367

Supplemental Content

Loading ...
Support Center